Deep learning-based interpretable prediction of recurrence of diffuse large B-cell lymphoma
{{output}}
Background: The heterogeneous and aggressive nature of diffuse large B-cell lymphoma (DLBCL) presents significant treatment challenges as up to 50% of patients experience recurrence of disease after chemotherapy. Upfront detectio... ...
